3 research outputs found
Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonist
Since the discovery of the endomorphins (EM), the postulated endogenous peptide agonists of the mu-opioid receptors, several analogues have been synthesized to improve their binding and pharmacological profiles. We have shown previously that a new analogue, cis-1S,2R-aminocyclohexanecarboxylic acid2-endomorphin-2 (ACHC-EM2), had elevated mu-receptor affinity, selectivity, and proteolytic stability over the parent compound. In the present work, we have studied its antinociceptive effects and receptor regulatory processes. ACHC-EM2 displayed a somewhat higher (60%) acute antinociceptive response than the parent peptide, EM2 (45%), which peaked at 10âmin after intracerebroventricular (icv) administration in the rat tail-flick test. Analgesic tolerance developed to the antinociceptive effect of ACHC-EM2 upon its repeated icv injection that was complete by a 10-day treatment. This was accompanied by attenuated coupling of mu-sites to G-proteins in subcellular fractions of rat brain. Also, the density of mu-receptors was upregulated by about 40% in the light membrane fraction, with no detectable changes in surface binding. Distinct receptor regulatory processes were noted in subcellular fractions of rat brains made tolerant by the prototypic full mu-agonist peptide, DAMGO, and its chloromethyl ketone derivative, DAMCK. These results are discussed in light of the recently discovered phenomenon, that is, the âso-called biased agonismâ or âfunctional selectivity
Upregulation of mu opioid receptors by voluntary morphine administration in drinking water
Morphine was provided to rats in drinking water for 21 days. Profound analgesic tolerance was detected
both in hot-plate and tail-flick tests. The density of [3H]DAMGO binding sites increased by 76% in
spinal cord membranes due to morphine exposure compared to those in opioid naive animals. Slightly
augmented [3H]DAMGO binding was measured in the synaptic plasma membranes, with a concomitant
decrease in the microsomal membranes, of morphine tolerant/dependent brains. These observations suggest
that the regulation of spinal mu opioid receptors might be different from those in the brain. It is
emphasized that the molecular changes underlying tolerance/dependence are influenced by several factors,
such as the tissue or subcellular fractions used, besides the obvious importance of the route of drug
administration. Results obtained after voluntary morphine intake further support the growing number of
experimental data that chronic morphine does not internalize/downregulate the mu opioid receptors in the
central nervous system